South Korea
· Delayed Price · Currency is KRW ViGenCell Statistics
Total Valuation
ViGenCell has a market cap or net worth of KRW 50.66 billion. The enterprise value is 9.27 billion.
| Market Cap | 50.66B |
| Enterprise Value | 9.27B |
Important Dates
The last earnings date was Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ViGenCell has 19.26 million shares outstanding. The number of shares has increased by 0.74% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 19.26M |
| Shares Change (YoY) | +0.74% |
| Shares Change (QoQ) | +0.35% |
| Owned by Insiders (%) | 7.12% |
| Owned by Institutions (%) | 4.05% |
| Float | 13.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.78 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.61 |
| EV / Sales | 168.47 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.69 |
Financial Position
The company has a current ratio of 6.26, with a Debt / Equity ratio of 0.12.
| Current Ratio | 6.26 |
| Quick Ratio | 6.23 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.55 |
| Interest Coverage | -48.94 |
Financial Efficiency
Return on equity (ROE) is -21.13% and return on invested capital (ROIC) is -14.07%.
| Return on Equity (ROE) | -21.13% |
| Return on Assets (ROA) | -13.70% |
| Return on Capital (ROIC) | -14.07% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.65% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -47.65% |
| 50-Day Moving Average | 3,445.10 |
| 200-Day Moving Average | 4,211.43 |
| Relative Strength Index (RSI) | 25.01 |
| Average Volume (20 Days) | 41,893 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ViGenCell had revenue of KRW 55.00 million and -15.31 billion in losses. Loss per share was -799.40.
| Revenue | 55.00M |
| Gross Profit | 6.83M |
| Operating Income | -17.98B |
| Pretax Income | -15.31B |
| Net Income | -15.31B |
| EBITDA | -13.94B |
| EBIT | -17.98B |
| Loss Per Share | -799.40 |
Balance Sheet
The company has 48.84 billion in cash and 7.44 billion in debt, giving a net cash position of 41.40 billion or 2,149.00 per share.
| Cash & Cash Equivalents | 48.84B |
| Total Debt | 7.44B |
| Net Cash | 41.40B |
| Net Cash Per Share | 2,149.00 |
| Equity (Book Value) | 64.56B |
| Book Value Per Share | 3,351.51 |
| Working Capital | 41.56B |
Cash Flow
In the last 12 months, operating cash flow was -13.17 billion and capital expenditures -264.70 million, giving a free cash flow of -13.44 billion.
| Operating Cash Flow | -13.17B |
| Capital Expenditures | -264.70M |
| Free Cash Flow | -13.44B |
| FCF Per Share | -697.43 |
Margins
| Gross Margin | 12.42% |
| Operating Margin | -32,698.39% |
| Pretax Margin | -27,844.30% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -24,427.46% |
Dividends & Yields
ViGenCell does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.74% |
| Shareholder Yield | -0.74% |
| Earnings Yield | -30.40% |
| FCF Yield | -26.52% |
Stock Splits
The last stock split was on June 8, 2022. It was a forward split with a ratio of 2.
| Last Split Date | Jun 8, 2022 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
ViGenCell has an Altman Z-Score of 4.68.
| Altman Z-Score | 4.68 |
| Piotroski F-Score | n/a |